SI1718649T1 - Derivati imidazo 1,2-c pirimidinilocetne kisline - Google Patents

Derivati imidazo 1,2-c pirimidinilocetne kisline

Info

Publication number
SI1718649T1
SI1718649T1 SI200530724T SI200530724T SI1718649T1 SI 1718649 T1 SI1718649 T1 SI 1718649T1 SI 200530724 T SI200530724 T SI 200530724T SI 200530724 T SI200530724 T SI 200530724T SI 1718649 T1 SI1718649 T1 SI 1718649T1
Authority
SI
Slovenia
Prior art keywords
imidazo
diseases
allergic
pyrimidinylacetic acid
acid derivative
Prior art date
Application number
SI200530724T
Other languages
English (en)
Inventor
Tai-Wei Ly
Takashi Yoshino
Yuki Takekawa
Takuya Shintani
Hiromi Sugimoto
Kevin B Bacon
Klaus Urbahns
Original Assignee
Actimis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actimis Pharmaceuticals Inc filed Critical Actimis Pharmaceuticals Inc
Publication of SI1718649T1 publication Critical patent/SI1718649T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI200530724T 2004-01-31 2005-01-19 Derivati imidazo 1,2-c pirimidinilocetne kisline SI1718649T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04002144 2004-01-31
EP05706922A EP1718649B1 (en) 2004-01-31 2005-01-19 Imidazo 1,2-c pyrimidinylacetic acid derivatives
PCT/EP2005/000475 WO2005073234A2 (en) 2004-01-31 2005-01-19 Imidazo[1,2-c]pyrimidinylacetic acid derivatives

Publications (1)

Publication Number Publication Date
SI1718649T1 true SI1718649T1 (sl) 2009-10-31

Family

ID=34814234

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530724T SI1718649T1 (sl) 2004-01-31 2005-01-19 Derivati imidazo 1,2-c pirimidinilocetne kisline

Country Status (24)

Country Link
US (1) US7750014B2 (sl)
EP (1) EP1718649B1 (sl)
JP (1) JP4996257B2 (sl)
KR (1) KR101207428B1 (sl)
CN (1) CN100584844C (sl)
AT (1) ATE433452T1 (sl)
AU (1) AU2005209381B2 (sl)
BR (1) BRPI0507123A (sl)
CA (1) CA2551778C (sl)
CY (1) CY1109274T1 (sl)
DE (1) DE602005014849D1 (sl)
DK (1) DK1718649T3 (sl)
ES (1) ES2326896T3 (sl)
HK (1) HK1101969A1 (sl)
IL (1) IL177083A (sl)
MX (1) MXPA06007674A (sl)
NO (1) NO20063878L (sl)
NZ (1) NZ548396A (sl)
PL (1) PL1718649T3 (sl)
PT (1) PT1718649E (sl)
RU (1) RU2373208C2 (sl)
SI (1) SI1718649T1 (sl)
WO (1) WO2005073234A2 (sl)
ZA (1) ZA200605387B (sl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ556657A (en) 2004-12-27 2010-10-29 Actelion Pharmaceuticals Ltd 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
NZ574705A (en) 2006-08-07 2011-12-22 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
WO2008125627A1 (en) * 2007-04-13 2008-10-23 Novartis Ag Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
WO2008156780A1 (en) * 2007-06-21 2008-12-24 Actimis Pharmaceuticals, Inc. Particulates of a crth2 antagonist
WO2009042138A1 (en) * 2007-09-25 2009-04-02 Actimis Pharmaceuticals, Inc. Alkylthio pyrimidines as crth2 antagonists
CL2008002827A1 (es) * 2007-09-25 2009-11-27 Actimis Pharmaceuticals Inc Compuestos derivados de 2-s-bencil pirimidina, antagonistas del receptor crth2; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades alergicas mediadas por eosinofilos y basofilos, tales como asma, rinitis alergica, dermatitis atopica, conjuntivitis alergica, sinusitis y psoriasis, entre otras
WO2009102893A2 (en) 2008-02-14 2009-08-20 Amira Pharmaceuticals, Inc. CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
US8426449B2 (en) 2008-04-02 2013-04-23 Panmira Pharmaceuticals, Llc Aminoalkylphenyl antagonists of prostaglandin D2 receptors
JP5586606B2 (ja) * 2008-09-02 2014-09-10 アクチミス ファーマシューティカルズ インコーポレーテッド Ｃｒｔｈ２アンタゴニストとしての同位体富化されたピリミジン−５−イル酢酸誘導体
WO2010057118A2 (en) 2008-11-17 2010-05-20 Amira Pharmaceuticals, Inc. Heterocyclic antagonists of prostaglandin d2 receptors
BR112012024114B1 (pt) 2010-03-22 2021-02-09 Idorsia Pharmaceuticals Ltd Compostos derivados de 3-(heteroarilamino)-1,2,3,4-tetrahidro-9h-carbazol, uso dos mesmos, e, composição farmacêutica
RU2013104506A (ru) 2010-07-05 2014-08-10 Актелион Фармасьютиклз Лтд 1-фенилзамещенные производные гетероциклила и их применение в качестве модуляторов рецептора простагландина d2
EP2682394A1 (de) 2010-07-09 2014-01-08 Bayer Intellectual Property GmbH 1H-Pyrazolo[3,4-b]pyridin-Triazine Verbindungen und ihre Verwendung zur Behandlung bzw. Prophylaxe von Herz-Kreislauf-Erkrankungen
DE102010031149A1 (de) 2010-07-09 2012-01-12 Bayer Schering Pharma Aktiengesellschaft Annellierte Pyrimidine und Triazine und ihre Verwendung
DE102011003315A1 (de) 2011-01-28 2012-08-02 Bayer Schering Pharma Aktiengesellschaft Annellierte Pyrimindine und Triazine und ihre Verwendung
EP2627178B1 (en) 2010-10-11 2018-05-02 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as crth2 antagonists
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
BR112013026283A8 (pt) 2011-04-14 2018-01-30 Actelion Pharmaceuticals Ltd derivados de ácido 7-(heteroaril-amino)-6,7,8,9-tetrahidropirido[1,2-a]indol acético e seu uso como moduladores do receptor d2 de prostaglandina
EP2790696A1 (en) 2011-12-16 2014-10-22 Atopix Therapeutics Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
KR20140107550A (ko) 2011-12-21 2014-09-04 액테리온 파마슈티칼 리미티드 헤테로시클릴 유도체 및 프로스타글란딘 ｄ2 수용체 조절제로서의 그의 용도
DE102012200360A1 (de) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituierte Triazine und ihre Verwendung
DE102012200349A1 (de) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituierte annellierte Pyrimidine und Triazine und ihre Verwendung
ES2644781T3 (es) 2012-03-06 2017-11-30 Bayer Intellectual Property Gmbh Azabiciclos sustituidos y su uso
WO2014006585A1 (en) 2012-07-05 2014-01-09 Actelion Pharmaceuticals Ltd 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
SI3119779T1 (sl) 2014-03-17 2018-10-30 Idorsia Pharmaceuticals Ltd Derivati azaindolocetne kisline in njihova uporaba kot modulatorji prostaglandinskega receptorja D2
AU2015233046A1 (en) 2014-03-18 2016-11-03 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
WO2017046125A1 (en) 2015-09-15 2017-03-23 Actelion Pharmaceuticals Ltd Crystalline forms
KR20190103507A (ko) 2018-02-12 2019-09-05 김강민 지하철 혼잡도 알림 시스템
TW202100015A (zh) 2019-02-28 2021-01-01 瑞士商先正達農作物保護公司 具有含硫取代基之殺有害生物活性雜環衍生物
CN114681438B (zh) * 2022-05-17 2024-03-19 中国医学科学院基础医学研究所 二甲双胍及其它含胍化合物在逆转Gal-10结晶趋势并缓解相关疾病中应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
GB9125842D0 (en) 1991-12-04 1992-02-05 Ici Plc Heterocyclic derivatives
JP2001302667A (ja) * 2000-04-28 2001-10-31 Bayer Ag イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
EP1413306A1 (en) 2002-10-21 2004-04-28 Warner-Lambert Company LLC Tetrahydroquinoline derivatives as CRTH2 antagonists
AU2003297398B2 (en) 2002-12-20 2009-09-24 Amgen Inc. Asthma and allergic inflammation modulators
EP1471057B1 (en) * 2003-04-25 2006-01-18 Actimis Pharmaceuticals, Inc. Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2

Also Published As

Publication number Publication date
DE602005014849D1 (de) 2009-07-23
HK1101969A1 (en) 2007-11-02
JP2007519659A (ja) 2007-07-19
RU2373208C2 (ru) 2009-11-20
CY1109274T1 (el) 2014-07-02
DK1718649T3 (da) 2009-08-24
JP4996257B2 (ja) 2012-08-08
AU2005209381B2 (en) 2011-06-30
PT1718649E (pt) 2009-08-06
KR20060130187A (ko) 2006-12-18
US7750014B2 (en) 2010-07-06
CA2551778A1 (en) 2005-08-11
KR101207428B1 (ko) 2012-12-04
IL177083A0 (en) 2006-12-10
PL1718649T3 (pl) 2009-11-30
RU2006131304A (ru) 2008-03-10
ATE433452T1 (de) 2009-06-15
WO2005073234A2 (en) 2005-08-11
EP1718649A2 (en) 2006-11-08
CN1938310A (zh) 2007-03-28
US20090012102A1 (en) 2009-01-08
CA2551778C (en) 2013-10-22
CN100584844C (zh) 2010-01-27
WO2005073234A3 (en) 2005-10-06
ZA200605387B (en) 2008-05-28
AU2005209381A1 (en) 2005-08-11
EP1718649B1 (en) 2009-06-10
IL177083A (en) 2011-10-31
NO20063878L (no) 2006-10-11
MXPA06007674A (es) 2006-09-04
NZ548396A (en) 2010-06-25
BRPI0507123A (pt) 2007-06-19
ES2326896T3 (es) 2009-10-21

Similar Documents

Publication Publication Date Title
HK1101969A1 (en) Imidazo [1,2-c] pyrimidinylacetic acid derivatives
TW200505873A (en) Pyrimidine derivatives
EP2380891B1 (de) Substituierte Piperidino-Dihydrothienopyrimidine
EP2400962B1 (de) Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
NO20052076L (no) Fuserte azol-pyrimidinderivater.
WO2004011427A3 (en) Substituted benzanilides as modulators of the ccr5 receptor
TW200716648A (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
WO2004010943A3 (en) Substituted benzanilides as modulators of the ccr5 receptor
ZA201100526B (en) Triazolo [4,5-d]pyramidine derivatives and their use as purine receptor antagonists
SG155943A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
CN105814043B (zh) 用作tnf活性调节剂的三唑并吡啶衍生物
ATE424402T1 (de) Imidazopyridinverbindungen
PT1608374E (pt) Derivados de 2-fenoxi- e 2-fenilsulfonamida com actividade antagonista do ccr3 para o tratamento da asma e de outras desordens inflamatórias e imunológicas
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
NO20091489L (no) Tiazolpyrazolopyridiner som CRF1 reseptorantagonister
MX2009003100A (es) Inhibidores de fosfodiesterasa tipo iv.
WO2004010942A3 (en) Substituted heterocyclic compounds as modulators of the ccr5 receptor
WO2009085880A3 (en) C-21 thioethers as glucocorticoid receptor agonists
DE60011997D1 (de) SUBSTITUIERTE BENZO(1,2-b:5,4-b')DIPYRAN-4-AMINE ALS CCR5 MODULATOREN
US20050101613A1 (en) Substituted pyrimidine derivatives
DE602006016244D1 (de) Diazaspiro-ä4,4ü-nonanderivate als neurokinin-(nk1)-antagonisten
Xia et al. Substituted dipiperidine alcohols as potent CCR2 antagonists
TW200745087A (en) CCR5 antagonists useful for treating HIV
WO2005058898A3 (en) Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors
Edwards et al. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor